APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon et al.|PLoS Medicine|2017Cited by 610
Expectancy and belief modulate the neuronal substrates of pain treated by acupunctureJérémie Pariente, George Lewith, Peter White et al.|NeuroImage|2005Cited by 387
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Jorge J. Llibre‐Guerra et al.|Nature Medicine|2021Cited by 365
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trialRandall J. Bateman, Bruno Dubois, Yan Li et al.|The Lancet Neurology|2025Cited by 39